COMMUNIQUÉS West-GlobeNewswire

Apnimed Named 2024 Best Places to Work Company by the Boston Business Journal

07/05/2024 - 14:00

CAMBRIDGE, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- The Boston Business Journal has named Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of [...]

Sirona Biochem Engages Stonegate Healthcare Partners

07/05/2024 - 14:00

VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) has announced a partnership with Stonegate Healthcare Partners. Stonegate is a leading corporate [...]

Windtree Therapeutics Regains Compliance with Nasdaq

07/05/2024 - 14:00

WARRINGTON, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for [...]

RadNet’s Lenox Hill Radiology to Host Mother’s Day Mammogram Screening Parties in New York City

07/05/2024 - 13:50

WNBA icon Sheryl Swoopes and New York elected officials will attend “MammoGlam” events in Harlem and the Bronx to promote breast health and equitable access NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. ( [...]

Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment

07/05/2024 - 13:46

Vancouver, Canada, May 07, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results

07/05/2024 - 13:35

IRVINE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies for patients with rare [...]

Lexeo Therapeutics to Participate in Upcoming Investor Conferences

07/05/2024 - 13:30

NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4- [...]

Arbutus to Participate in Two Upcoming Investor Conferences

07/05/2024 - 13:30

WARMINSTER, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for [...]

Altimmune to Participate at Two Upcoming Investor Conferences

07/05/2024 - 13:30

GAITHERSBURG, Md., May 07, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate and be [...]

Enable Injections Expands Strategic Partnership with Roche

07/05/2024 - 13:30

CINCINNATI, May 07, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc.  ("Enable"), a leading innovator in developing and manufacturing the enFuse ® platform of wearable drug delivery device technology, today announced [...]

ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer

07/05/2024 - 11:00

Leveraging profound knowledge in radiopharmaceutical drug development and commercial planning, Dr. Meyrick will lead the medical team in further developing and delivering on ITM's pipeline strategy After a career [...]

Coloplast Finance B.V. - Interim Financial Report, H1 2023/24

07/05/2024 - 09:51

H1 2023/24 Interim financial results, H1 2023/24 1 October 2023 - 31 March 2024 Coloplast delivered a solid Q2 with 8% organic growth and an EBIT margin 1) of 27%. Reported revenue in DKK grew 9% with 4%-points [...]

EyeDNA Therapeutics Announces Positive 24-month Data Presented at ARVO from Ongoing Phase I/II Trial of HORA-PDE6b Gene Therapy in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b

07/05/2024 - 09:00

Clinically meaningful benefit in visual functions and good safety profile of HORA-PDE6b is confirmed at 24-month follow-up Phase I/II results will be discussed with US and European health authorities to define optimal [...]

CMR Surgical appoints Shlomi Cohen as Chief Financial Officer

07/05/2024 - 08:00

CMR Surgical appoints Shlomi Cohen as Chief Financial Officer Shlomi Cohen is a medical devices expert with significant financial and operational experience. CAMBRIDGE, UK – 7 May 2024, 07:00 (BST). CMR Surgical (CMR or [...]

Memo Therapeutics increases Series C financing to CHF 45 million

07/05/2024 - 08:00

PRESS RELEASE Memo Therapeutics increases Series C financing to CHF 45 million Additional CHF 20 million raised from new investors Ysios Capital and Kurma Partners as well as from existing investors Proceeds will be [...]

Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025

07/05/2024 - 07:30

ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD / MANAGEMENT / AUDITORS 7 May 2024 at 08.30 EEST Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025 Olli Huotari , Senior Vice [...]

Coloplast strengthens ostomy care portfolio with three significant product launches

07/05/2024 - 07:04

The company has received reimbursement approval in the UK for Heylo™, the world’s first digital leakage notification system, and expands its SenSura® Mio ostomy range with two new products. As part of our 2025 strategy [...]

Coloplast A/S - Announcement no. 02/2024 - Interim Financial Report, H1 2023/24

07/05/2024 - 07:00

H1 2023/24 Interim financial results, H1 2023/24 1 October 2023 - 31 March 2024 Coloplast delivered a solid Q2 with 8% organic growth and an EBIT margin 1) of 27%. Reported revenue in DKK grew 9% with 4%-points [...]

Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates

07/05/2024 - 07:00

Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates Q1 financial highlights Total revenues of €32.8 million, including sales of €32.1 million, on track to meet anticipated full year [...]